TSHR; NPSR1; CXCR1; | |
ADRA2C; GPBAR1; DRD4; | |
ALPL; RECQL; PLA2G1B; BLM; TDP1; GLA; CTDSP1; P4HB; PIK3R1; GLO1; HPGD; HSD11B1; MPO; HSD17B1; AKR1B1; HSD17B2; HSD17B10; ALOX15; ALDH1A1; ALOX12; AKR1B10; NOX4; PYGL; POLB; | |
PTPN1; PTPRF; PTPN2; ACP1; | |
GAA; | |
TRPA1; | |
MET; CAMK2B; CSNK2A1; AKT1; DAPK1; AXL; NEK2; FLT3; NEK6; SRC; IGF1R; PTK2; AURKB; GSK3B; CDK1; PIM1; NUAK1; ALK; KDR; PKN1; | |
CA12; CA14; CA3; CA7; CA5A; CA9; CA4; CA6; CA2; CA1; | |
AR; | |
NR1H4; | |
ESRRA; | |
RORC; | |
KDM4E; | |
MAOA; ALOX5; PTGS1; TYR; XDH; | |
MMP13; MMP3; MMP2; MMP9; | |
BACE1; | |
AHR; STAT6; HIF1A; NFKB1; TP53; | |
ABCC1; ABCG2; | |
LMNA; MAPT; THPO; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | BACE1 | Beta-secretase 1 | P56817 | CHEMBL4822 |
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2C8 | Cytochrome P450 2C8 | P10632 | CHEMBL3721 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.551E-13 | 1.351E-10 | CA1, CA12, CA2, CA3, CA4, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.415E-12 | 1.814E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 8.823E-12 | 4.468E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C8, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.490E-11 | 7.036E-09 | CYP1A2, CYP2A6, CYP2C19, CYP2C8, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.006E-08 | 2.029E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 3.242E-07 | 4.469E-05 | CYP1A2, CYP2C8, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 5.134E-07 | 6.694E-05 | ABCC1, ALOX12, ALOX15, ALOX5, PLA2G1B |
BP | GO:0008152; metabolic process | GO:0019372; lipoxygenase pathway | 1.173E-06 | 1.389E-04 | ALOX12, ALOX15, ALOX5, HPGD |
BP | GO:0009987; cellular process | GO:0071407; cellular response to organic cyclic compound | 2.041E-06 | 2.245E-04 | AKT1, ALPL, AR, BLM, CYP1A1, CYP1B1, FLT3, NFKB1, NOX4, RORC, SRC |
BP | GO:0008152; metabolic process | GO:0018105; peptidyl-serine phosphorylation | 2.285E-06 | 2.406E-04 | AKT1, AURKB, CAMK2B, CDK1, GSK3B, NEK6, PKN1, SRC |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00040 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.396E-02 | 2.779E-02 | AKR1B10; AKR1B1 |
hsa00051 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.113E-02 | 2.408E-02 | AKR1B10; AKR1B1 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 1.459E-05 | 9.693E-05 | AKR1B10; GAA; AKR1B1; GLA |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.583E-10 | 1.421E-08 | HSD11B1; HSD17B1; CYP1A2; HSD17B2; CYP1A1; CYP1B1; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.204E-06 | 1.215E-05 | CYP2A6; CYP1A2; XDH |
hsa00350 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.323E-02 | 2.765E-02 | MAOA; TYR |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 4.683E-05 | 2.489E-04 | MAOA; CYP1A2; CYP1A1; CYP1B1 |
hsa00561 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.219E-03 | 8.390E-03 | AKR1B10; AKR1B1; GLA |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 7.953E-10 | 2.113E-08 | CYP2C9; CYP2C8; PLA2G1B; ALOX5; ALOX15; ALOX12; CYP2C19; PTGS1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 9.003E-11 | 8.373E-09 | CYP2C9; CYP2C8; PLA2G1B; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Visceral leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Infections disease | A00-B99 | MPO |
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | HCV infection | B17.1, B18.2 | MMP3 |
A00-B99: Certain infectious and parasitic diseases | Leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3 |